CRVO
CervoMed Inc. - Common Stock (CRVO)
$64
About CervoMed Inc. - Common Stock (CRVO)
CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. The company was founded in1995 and is headquartered in Boston, MA.
Details
Daily high
$9.20
Daily low
$8.61
Price at open
$8.80
52 Week High
$25.69
52 Week Low
$1.80
Market cap
75.2M
Dividend yield
0.00%
Volume
246,500
Avg. volume
687,207
P/E ratio
-4.28
CervoMed Inc. - Common Stock News
Details
Daily high
$9.20
Daily low
$8.61
Price at open
$8.80
52 Week High
$25.69
52 Week Low
$1.80
Market cap
75.2M
Dividend yield
0.00%
Volume
246,500
Avg. volume
687,207
P/E ratio
-4.28